I wouldn't say NAVB has more nuclear experience! LS is the first "pharma" product. If you want to talk about nuclear experience, you may want to look at GE, Abbott, and Siemens medical. I know because I work on medical devices for Siemens.
You are just a blind pumper. z3peru has more intelligent discussion. What are you? Some twenty years old day trader????
Do car manufactures starting selling cars in just 10 states? Noooo, you go all out. You are the idiot that will accept any spin.
More spin from Pykett...Cardinal is so good at what they do...they will only go and make sale call to 600 hospitals. Pykett needs to go out and sell it himself. Maybe he reduces his salary and use that money to hire sale people?
"2100 of the 5000 hospitals in the US do lymphatic mapping procedures. Cardinal is initially focusing on the top 600."
F Cardinal. Why don't they go after all 2100. What the F do they do if they don't go out and sell?
OK, I was too quick to type...NAV 5001 came from a bankrupted company but NAV 4694 came from Astra....so you are half right!
If these two are so great, why did AstraZeneca license them to NAVB instead of developing it themselves? Imagine you have a killer product potential but you gave it away to NAVB? To me this is another low profit products that AstraZeneca don't care about. NAVB will never make big money with it.
g) NAV 4694...Huge potential in Alzheimers...Science so far is very exciting
h) NAV 5001... making fantastic progress in Parkinson's Disease and Dementia with Lewy Bodies. NAV5001 takes 45 minutes to detect while the current Datscan takes 4-6 hours.
That means one thing and only one thing: LS is a dud in term of profit generating product. The science works but the product can't sell well.
You can't go to investor conference saying there is no more dilutive financing and then turn around and does it many times.
You can't say EU partner is here and working on paperworks and then turn around not saying a word (i.e. there are problems).
What's the point for that asshat Pykett to go to investor conference tomorrow? Plus, he is dividing his time between Dublin, OH and MA (expensive second office). This means it costs the shareholders a fortune just to fly this asshat back and forth. I guess he doesn't like tele-conference.
I'm in CLF with you. I don't know much about this stock except that it is about iron ore. They have 2 negatives: high debt and no future CEO; the current one is retiring. Do you just swing trade it?